The use of mmp inhibitors for the treatment of ocular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/66 (2006.01) A61K 31/16 (2006.01) A61K 31/19 (2006.01) A61K 31/325 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/4035 (2006.01) A61K 31/445 (2006.01)

Patent

CA 2256303

The present invention relates to the use of matrix metalloproteinase inhibitors,preferably those which display specihcity for matrix metalloproteinases-2 or 9, in the treatment or prevention of ocular angiogenesis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of mmp inhibitors for the treatment of ocular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of mmp inhibitors for the treatment of ocular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of mmp inhibitors for the treatment of ocular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1739764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.